Survival with Cemiplimab in Recurrent Cervical Cancer
- DOI
- 10.1056/nejmoa2112187
- Published
- 2022-02-10
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2112187,
title = {Survival with Cemiplimab in Recurrent Cervical Cancer},
author = {Krishnansu S. Tewari and Bradley J. Monk and Ignace Vergote and Austin Miller and Andreia C. de Melo and Hee-Seung Kim and Yong Man Kim and Alla Lisyanskaya and Vanessa Samouëlian and Domenica Lorusso and Fernanda Damian and Chih-Long Chang and Evgeniy A. Gotovkin and Shunji Takahashi and Daniella Ramone and Joanna Pikiel and Beata Maćkowiak-Matejczyk and Eva M. Guerra Alía and Nicoletta Colombo and Yulia Makarova and Danny Rischin and Stephanie Lheureux and Kosei Hasegawa and Keiichi Fujiwara and Jingjin Li and Shaheda Jamil and Vladimir Jankovic and Chieh-I Chen and Frank Seebach and David M. Weinreich and George D. Yancopoulos and Israel Lowy and Melissa Mathias and Matthew G. Fury and Ana Oaknin},
year = {2022},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2112187},
url = {https://doi.org/10.1056/nejmoa2112187}
}RIS
TY - JOUR TI - Survival with Cemiplimab in Recurrent Cervical Cancer AU - Krishnansu S. Tewari AU - Bradley J. Monk AU - Ignace Vergote AU - Austin Miller AU - Andreia C. de Melo AU - Hee-Seung Kim AU - Yong Man Kim AU - Alla Lisyanskaya AU - Vanessa Samouëlian AU - Domenica Lorusso AU - Fernanda Damian AU - Chih-Long Chang AU - Evgeniy A. Gotovkin AU - Shunji Takahashi AU - Daniella Ramone AU - Joanna Pikiel AU - Beata Maćkowiak-Matejczyk AU - Eva M. Guerra Alía AU - Nicoletta Colombo AU - Yulia Makarova AU - Danny Rischin AU - Stephanie Lheureux AU - Kosei Hasegawa AU - Keiichi Fujiwara AU - Jingjin Li AU - Shaheda Jamil AU - Vladimir Jankovic AU - Chieh-I Chen AU - Frank Seebach AU - David M. Weinreich AU - George D. Yancopoulos AU - Israel Lowy AU - Melissa Mathias AU - Matthew G. Fury AU - Ana Oaknin PY - 2022 JO - New England Journal of Medicine DO - 10.1056/nejmoa2112187 UR - https://doi.org/10.1056/nejmoa2112187 ER -
APA
Tewari, K. S., Monk, B. J., Vergote, I., Miller, A., Melo, A. C. D., Kim, H., Kim, Y. M., Lisyanskaya, A., Samouëlian, V., Lorusso, D., Damian, F., Chang, C., Gotovkin, E. A., Takahashi, S., Ramone, D., Pikiel, J., Maćkowiak-Matejczyk, B., Alía, E. M. G., Colombo, N., Makarova, Y., Rischin, D., Lheureux, S., Hasegawa, K., Fujiwara, K., Li, J., Jamil, S., Jankovic, V., Chen, C., Seebach, F., Weinreich, D. M., Yancopoulos, G. D., Lowy, I., Mathias, M., Fury, M. G., & Oaknin, A. (2022). Survival with Cemiplimab in Recurrent Cervical Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2112187
Source records
- crossref · retrieved 2026-09-26T03:19:41.798Z